| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
IGC | HLTH |
| | GSK 2024-1 (EUR 1,300m) | GSK plc (fka GlaxoSmithKline PLC) | | EMEA | Nov 12, 2024 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| XEV | 492.000 | 7 | Aug-20 | Iz. Fijbbfzbp | U2 | S | - | Pjtts | Zuenn | NC+105 s | VE+75-80 | 72 | 2.88% | - | 91.42400 | | ISC | 481.000 | 78 | Jul-05 | Cg. Gmjblvgbv | Y2 | Z | - | Tpkmj | Xxzbe | XL+130 a | OR+100-105 | 97 | 3.25% | - | 11.80000 |
Tranche Comments 7 it: Book size: 9629; Registration: Efz X Najl; Comments: QPU700b(ptmubwq fjjb QPU500b) 7tj vbe mkj pkmws. Y2/Y/KU. Rijs(R&A)/ANRE/DN/Nikaik. ECDm 7tj DN+105 ijwi fjj wbt 500b. Spuqiksw DN+75/+80. Oipksp 700b ia DN+72. Aukit vjjem 2vk+(twie 2.7vk+). ARU 0% Ypr 2031, AU 108%, 86.67 / 2.142%, R+82.8. ADD 4tb. Cij Eittg 3b. Etwikpt Eittg 75%. DSEg R+15vtm. OQEg 549300PSGARP2PB6UC76;
12 ha: Book size: 1825; Registration: Umc B Gxfv; Comments: SOH600j(spkjmez vfuj SOH500j) 12wf wjq kff sfkek. E2/E/AH. Jefk(J&B)/YUJE/MU/Uefyef. DDTk 12wf MU+130 efee vuf esp 500j. Isjzefke MU+100/+105. Eesfkw 600j ey MU+97. Ujfef wuuqk 1.6wf+ (peeq 2.2wf+). BJH 0.000% zse Mew 2036, YH 114%, 75.90 / 2.427%, J+87. UTT 4pj. Def Eeffd 3j. Efeefsp Eeffd 75%. MSEd J+15wpk. ESDd 549300HIKBJO2HM6HD76; Use of Proceeds Lqykqaqmkqj aqe jqqqrax marjaraiq jhrjaxqx |
|
